A significant burden of neuropsychiatric comorbidities exists among patients with PPD and various psychophysiological disorders.

President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.

Trump's new EHR system will let people upload medical records and use QR codes to share details with health care providers.

Guselkumab was an effective treatment for plaque psoriasis with extensive body involvement among patients with skin of color.

Weight loss of at least 5% was associated with improvements in PROs among individuals with RMDs taking weight loss medications.

Adults engaged in risky drinking should be provided brief behavioral counseling interventions to reduce use, USPSTF says.

The EPA has proposed to rescind the 2009 decision that allowed it to regulate greenhouse gases as pollutants under the Clean Air Act.

After adjusting for confounding factors, patients with CSU experience worse health outcomes and quality of life than patients with AD or PsO.

The UP-AA clinical program includes 2 studies assessing the safety and efficacy of upadacitinib in adults and adolescent patients with severe alopecia areata.

The majority of patients with skin of color and scalp psoriasis who were treated with guselkumab achieved significant scalp clearance.

President Trump ordered the reinstatement of the Presidential Fitness Test program, which tests children's athletic abilities.

New research suggests that the survival benefits observed with different treatments for advanced melanoma vary according to the site of metastasis.